Maizel Ari
Chief Commercial Officer · 4 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-22 | AXSM | Axsome Therapeutics, Inc. | Sale | 7,500 | $182.42 | $1.4M | filing |
| 2026-04-22 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 7,500 | $70.73 | $530,475.00 | filing |
| 2026-01-21 | AXSM | Axsome Therapeutics, Inc. | Sale | 7,500 | $184.44 | $1.4M | filing |
| 2026-01-21 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 7,500 | $70.73 | $530,475.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.